Dexcom (DXCM) FCF Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,191.00 |
| Dec 31, 2025 | -440.00 |
| Sep 30, 2025 | 2,791.00 |
| Jun 30, 2025 | -317.00 |
| Mar 31, 2025 | 1,707.00 |
| Dec 31, 2024 | -564.00 |
| Sep 30, 2024 | -242.00 |
| Jun 30, 2024 | 1,601.00 |
| Mar 31, 2024 | 2,634.00 |
| Dec 31, 2023 | 311.00 |
| Sep 30, 2023 | 1,007.00 |
| Jun 30, 2023 | 224.00 |
| Mar 31, 2023 | 2,390.00 |
| Dec 31, 2022 | -221.00 |
| Sep 30, 2022 | 1,174.00 |
| Jun 30, 2022 | 1,033.00 |
| Mar 31, 2022 | 1,102.00 |
| Dec 31, 2021 | 618.00 |
| Sep 30, 2021 | 1,677.00 |
| Jun 30, 2021 | -1,365.00 |
| Mar 31, 2021 | -417.00 |
| Dec 31, 2020 | 1,988.00 |
| Sep 30, 2020 | 993.00 |
| Jun 30, 2020 | 1,039.00 |
| Mar 31, 2020 | -141.00 |
| Dec 31, 2019 | 1,712.00 |
| Sep 30, 2019 | 15.00 |
| Jun 30, 2019 | 145.00 |
| Mar 31, 2019 | 357.00 |
| Dec 31, 2018 | 67.00 |
| Sep 30, 2018 | 1,377.00 |
| Jun 30, 2018 | 1,592.00 |
| Mar 31, 2018 | 692.00 |
| Dec 31, 2017 | 4,671.00 |
| Sep 30, 2017 | 5,082.00 |
| Jun 30, 2017 | 4,050.00 |
| Mar 31, 2017 | 4,631.00 |
| Dec 31, 2016 | 6,484.00 |
| Sep 30, 2016 | 4,971.00 |
| Jun 30, 2016 | 2,422.00 |
| Mar 31, 2016 | 6,796.00 |
| Dec 31, 2015 | 10,116.00 |
| Sep 30, 2015 | 10,921.00 |